Table 1.
Patient characteristics
| PEG + M | AscPEG | P value | |
| Age (mean ± SD, yr) | 55 ± 13.8 | 54 ± 13.7 | 0.88 |
| Male subjects | 54% | 50% | 0.74 |
| BMI (mean ± SD, kg/m2) | 27 ± 4.7 | 27 ± 4.9 | 0.54 |
| Indication | |||
| Screening | 46% | 43% | 0.70 |
| Hematochezia | 13% | 13% | 0.95 |
| Abdominal pain | 14% | 12% | 0.75 |
| Change in bowel habits | 10% | 6% | 0.41 |
| Surveillance | 7% | 9% | 0.53 |
| Positive FOBT | 4% | 5% | 0.74 |
| Weight loss | 2% | 1% | 0.27 |
| Anemia | 2% | 5% | 0.31 |
| Diverticular disease | 0% | 2% | 0.20 |
| Others | 2% | 4% | 0.28 |
PEG + M: PEG electrolyte solution + menthol; AscPEG: Ascorbic acid PEG electrolyte solution.